Endocrinology
News
High caffeine levels may lower body fat, type 2 diabetes risks
Previous short-term studies have linked caffeine intake with reductions in weight and fat mass.
News
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.
Commentary
Three surprising studies on exercise restriction and an exercise sweet spot
New data ‘do not support universal restriction of vigorous exercise in patients with’ hypertrophic cardiomyopathy.
News
Do artificial sweeteners alter postmeal glucose, hunger hormones?
Drinking a sugar-sweetened beverage had a different effect on postprandial levels of glucose than drinking a no-or low-calorie nonnutritive...
Perspectives
What impact do carbs have on bone health?
A high–glycemic index diet has been associated with a greater risk for obesity and cardiovascular disease, with lower bone density, and an...
Conference Coverage
Bempedoic acid cuts CV events in statin-intolerant patients: CLEAR Outcomes
The CLEAR Outcomes trial establishes this new drug as an important addition to available nonstatin LDL cholesterol–lowering therapies, experts say...
Commentary
U.S. vs. French guidelines for osteoporosis treatment
New U.S. guidelines, compared with 2018 French guidelines.
News
‘Forever chemicals’ disrupt biological processes in children: Study
Per- and polyfluoroalkyl substances hurt thyroid hormone function, which affects growth and metabolism.
News
How to get started with prescribing and advising on CGM
Continuous glucose monitoring is gaining ground with both patients and providers because of an array of driving forces.
News
Diabetes drug tied to lower dementia risk
Risk for dementia is doubled in adults with T2DM, say the authors of a new paper.